Delex Healthcare Group Inc (DELX)

[Penny Stocks 2.0]

Nice filing out 
Bounce Mobile Systems, Inc. (OTC: BNCM) Supplemental Filing Company Provides Strategic 2025 Forward Guidance & Outlook post-Merger with DELEX Healthcare Group April 2025 — Bounce Mobile Systems, Inc. (OTC: BNCM) (“BNCM” or the “Company”) is pleased to provide shareholders with a comprehensive supplemental OTC MARKETS filing update on its 2025 outlook, continuing the momentum set forth in its successful 2024 merger with DELEX Healthcare Group, Inc., and reinforcing its strategic evolution into a fully integrated healthcare innovation company. As outlined in our previously published PR updates, BNCM’s transition into the healthcare sector under the leadership of the DELEX Group has marked a transformative era for the Company. This transition has brought forward a dynamic management structure, access to proprietary technologies, and an ambitious roadmap to position BNCM as a disruptive player in the healthcare innovation ecosystem. 2024 Milestones Recap 1. Strategic Merger with DELEX Healthcare Group, Inc. This merger laid the foundation for the Company’s pivot into advanced healthcare solutions, leveraging DELEX’s operational infrastructure, industry expertise, and growing network of healthcare assets. 2. Management and Control Shift to DELEX Group As announced in Q1 2024, the shift in control to DELEX brought in a highly experienced executive team with a proven record in scaling healthcare ventures, enhancing corporate governance, and driving shareholder value. 3. Roadmap Unveiled for Innovation and Market Penetration BNCM and DELEX introduced a multi-phase plan to integrate digital health technologies, expand service offerings, and establish a footprint in emerging medical markets. 4. Operational Realignment and Asset Optimization Throughout 2024, BNCM and DELEX is focused on consolidating its legacy operations, reallocating resources toward scalable healthcare initiatives, and exploring synergistic acquisitions within the health-tech space. 2025 Strategic Outlook and Forward Plans Looking ahead, BNCM and DELEX is fully committed to accelerating the deployment of innovative healthcare solutions and expanding its market reach through: 1. Delivering Continued Growth DELEX has posted strong growth for the past 15 years and now has over 200 staffs, 30 Products approved by the Philippines FDA, supplies to over 900 pharmacies and hospitals, 160 drug chains and over 380 dispensing medical doctors and clinics. DELEX will continue to develop in-demand high quality products, secure more innovative medical technologies, expand its distribution channels, formed strategic partnerships across the region, increase its pharmacy stores from 3 to 60 and actively participate in medical conventions and exhibitions.2. Delivering Innovative and Cutting-Edge Medical Technologies DELEX has introduced various advanced technologies, starting with the CADD-Solis infusion systems from Smiths Medical, Ultrasound for Cardiology from Philips, Neutraclear needleless connectors from CAIR LGL. Anesthesia Unit, Electrosurgical Unit, Surgical light, and Surgical table from SternMed GmbH. 3. International Expansion Strategy BNCM and DELEX are jointly evaluating entry points into high-growth international healthcare markets, with a focus on Southeast Asia and the Middle East, where scalable innovation is in high demand. 4. Joint Ventures with Specialized Clinics and Medical Institutions BNCM and DELEX is actively structuring strategic partnerships with regional clinics and hospital groups to roll out its digital health infrastructure, enhancing both access and efficiency in patient care. 5. M&A Pipeline and Technology Acquisitions BNCM and DELEX has identified several targets across the AI diagnostics, telehealth, and medical device segments, with negotiations underway to strengthen its intellectual property portfolio and expand service capabilities. 6. Investor and Stakeholder Engagement As transparency and alignment remain top priorities, the Company is committed to maintaining consistent communication with its shareholders, analysts, and institutional partners throughout its growth trajectory. Final Remarks “We are immensely proud of the progress made in 2024, and even more excited about what lies ahead in 2025,” said a BNCM spokesperson. “With DELEX’s leadership, technology, and global vision, Bounce Mobile Systems is no longer just transitioning — we are now executing on a bold mission to redefine access to innovative healthcare solutions.” About Bounce Mobile Systems, Inc. (BNCM) On July 2nd, 2024 press release, the Board of Directors of DELEX Healthcare Group Inc. (DELEX) and Bounce Mobile Systems Inc. (BNCM) has signed an agreement for the acquisition / merger between DELEX and BNCM. The Board of Directors of both DELEX and BNCM plan to complete the required merger within the coming weeks. About DELEX Healthcare Group, Inc. (DELEX) DELEX is on a mission to revolutionize the pharmaceutical and healthcare industry. As a Delaware-registered company, DELEX partnership with JMN Brothers Pharma Limited, Inc. and DLX Holdings, Inc., brought high-quality products to market. With a focus on innovation, regulatory excellence, and customer service, DELEX strives to meet the growing demands of the market while adhering to the highest standard of regulatory compliance and customer service excellence. For more information, visit - https://bncm.net and https://bncm.us